miR-483-5p-Containing exosomes treatment ameliorated deep vein thrombosis‑induced inflammatory response
European Journal of Pharmaceutics and Biopharmaceutics · 2024
DOI: 10.1016/j.ejpb.2024.114384 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Pharmaceutics and Biopharmaceutics, 2024. Verfasst von Jing Fan und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, The First Affiliated Hospital of Anhui Medical University, Hefei 230022, China. Hauptthemen laut MEDLINE: Exosomes, Venous Thrombosis, MicroRNAs, Human Umbilical Vein Endothelial Cells. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 50 Literaturangaben.
Themen: Thromboseprophylaxe
Abstract (Originalsprache)
Peripheral vascular condition, known as deep vein thrombosis (DVT), is a common ailment that may lead to deadly pulmonary embolism. Inflammation is closely connected to venous thrombosis, which results in blood stasis, leading to ischemia and hypoxia, as indicated by research. The objective of this research was to investigate the mechanism by which exosomes derived from adipose stem cells (ADSCs) prevent deep vein thrombosis. Our data showed that Exo-483 effectively reduced the thrombus weight in DVT rats by intravenous injection. Exo-483 decreased the expression of tissue factor (TF) protein, the influx of inflammatory cells into the thrombosed vein wall, and the levels of cytokines in the serum. Furthermore, Exo-483 suppressed the expression of Mitogen-activated protein kinase 1 (MAPK1) and decreased the expression of NLRP3 inflammasomes. In an oxygen-glucose deprivation (OGD) cell model, the tube-forming and migratory abilities of primary human umbilical vein endothelial cells (HUVEC) and EA.hy926 cells were suppressed by Exo-483 pretreatment.Exo-483 is also linked to regulating Dynamin-related protein 1 (DRP1) production downstream of MAPK1.By decreasing the mitochondrial localization and phosphorylation at the S616 site of DRP1, it diminishes the expression of NLRP3 inflammasomes. Moreover, according to Bioinformatics analysis, miR-483-5p was anticipated to target MAPK1. The research conducted by our team revealed that the miR-483-5p exosome derived from ADSCs exhibited anti-inflammatory properties through the modulation of downstream DRP1-NLRP3 expression by targeting MAPK1.The findings of this research propose that miR-483-5p may be regarded as an innovative treatment target for DVT.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Radiology, The First Affiliated Hospital of Anhui Medical University, Hefei 230022, China.
- Department of Radiology, The First Affiliated Hospital of Anhui Medical University, Hefei 230022, China. Electronic address: shwy110@163.com.
Zitieren
APA
Fan, J., Liu, S., Ye, W., Zhang, X., & Shi, W. (2024). miR-483-5p-Containing exosomes treatment ameliorated deep vein thrombosis‑induced inflammatory response. European Journal of Pharmaceutics and Biopharmaceutics. https://doi.org/10.1016/j.ejpb.2024.114384
Vancouver
Fan J, Liu S, Ye W, Zhang X, Shi W. miR-483-5p-Containing exosomes treatment ameliorated deep vein thrombosis‑induced inflammatory response. European Journal of Pharmaceutics and Biopharmaceutics. 2024. doi:10.1016/j.ejpb.2024.114384
BibTeX
@article{Fan2024,
author = {Fan, Jing and Liu, Sikai and Ye, Wenhai and Zhang, Xiujin and Shi, Wanyin},
title = {miR-483-5p-Containing exosomes treatment ameliorated deep vein thrombosis‑induced inflammatory response},
journal = {European Journal of Pharmaceutics and Biopharmaceutics},
year = {2024},
doi = {10.1016/j.ejpb.2024.114384}
}
EUVIMED